<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE MedlineCitationSet PUBLIC "-//NLM//DTD Medline Citation, 1st January 2007//EN"
                                    "http://www.nlm.nih.gov/databases/dtd/nlmmedline_070101.dtd">
<MedlineCitationSet>
<MedlineCitation Owner="PIP" Status="MEDLINE">
<PMID>12236137</PMID>
<DateCreated>
<Year>1980</Year>
<Month>01</Month>
<Day>03</Day>
</DateCreated>
<DateCompleted>
<Year>1980</Year>
<Month>01</Month>
<Day>03</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0044-278X</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>92</Volume>
<PubDate>
<Year>1928</Year>
</PubDate>
</JournalIssue>
<Title>Zeitschrift fÃ¼r Geburtshilfe und GynÃ¤kologie</Title>
</Journal>
<ArticleTitle>[A new hysteroscope and its practical use in gynecology]</ArticleTitle>
<Pagination>
<MedlinePgn>13-25</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Mikulicz-radecki</LastName>
<ForeName>F V</ForeName>
<Initials>FV</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Freund</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Author>
</AuthorList>
<Language>ger</Language>
<PublicationTypeList>
<PublicationType>English Abstract</PublicationType>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
<VernacularTitle>Ein neues Hysteroskop und seine praktische Anwendung in der Gynakologie.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Z Geburtshilfe Gynakol</MedlineTA>
<NlmUniqueID>0326204</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>J</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Diagnosis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Endometrial Neoplasms</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Endoscopy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Hysteroscopy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Physical Examination</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Research</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="PIP">116453</OtherID>
<OtherID Source="POP">00029606</OtherID>
<OtherAbstract Type="PIP">
<AbstractText>Improvements to Freund's uterine curettoscope (1924) are described a nd practical applications of the instrument are reported.  The lens of the instrument has been placed very close to the end, in order to visualize the tubes, a tube for the introduction of a sound or catheter has been added, a moveable joint was added to control the direction of the catheter, and the  currette was eliminated.  The resulting instrument, called the &quot;tube hysteroscope,&quot; has been used for examinations in 50 patients;  physiological data of great interest have been collected, and the instrument's usefulness in the diagnosis of uterine carcinoma, polyps, myoma, and tubal function has been demonstrat ed.  Uterine perforation occurred in 1 case, already complicated by tubal and ovarian infection.  The author recommends the strictest asepsis, and timing during the intermenstruum.</AbstractText>
</OtherAbstract>
<KeywordList Owner="PIP">
<Keyword MajorTopicYN="Y">Clinical Research</Keyword>
<Keyword MajorTopicYN="N">Endometrial Cancer</Keyword>
<Keyword MajorTopicYN="N">Endoscopy</Keyword>
<Keyword MajorTopicYN="N">Examinations And Diagnoses</Keyword>
<Keyword MajorTopicYN="Y">Hysteroscopy--history</Keyword>
<Keyword MajorTopicYN="N">Physical Examinations And Diagnoses</Keyword>
<Keyword MajorTopicYN="N">Research Methodology</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="PIP" Status="MEDLINE">
<PMID>12305346</PMID>
<DateCreated>
<Year>1980</Year>
<Month>01</Month>
<Day>03</Day>
</DateCreated>
<DateCompleted>
<Year>1980</Year>
<Month>01</Month>
<Day>03</Day>
</DateCompleted>
<DateRevised>
<Year>2003</Year>
<Month>11</Month>
<Day>14</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0368-3338</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>17</Volume>
<PubDate>
<Year>1934</Year>
</PubDate>
</JournalIssue>
<Title>The Japanese journal of obstetrics and gynecology</Title>
</Journal>
<ArticleTitle>A study on the birth control with an intrauterine instrument.</ArticleTitle>
<Pagination>
<MedlinePgn>210-4</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Ota</LastName>
<ForeName>T</ForeName>
<Initials>T</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Jpn J Obstet Gynecol</MedlineTA>
<NlmUniqueID>0376566</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>J</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Contraception</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Family Planning Services</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Intrauterine Devices</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="PIP">340001</OtherID>
<OtherID Source="POP">00017147</OtherID>
<OtherAbstract Type="PIP">
<AbstractText>A metallic spiral IUD was inserted in 1 region of a rabbit uterus and tied to the uterine wall to test its effectiveness in pregnancy prevention.  Within 1 week and after 20 days, pregnancy was hindered in the region where the device was present.  The action of the IUD was irrespective of its composition.  Changes in the uterine mucous membrane were generally absent, and the uterus was without inflammatory findings and without necrosis or atrophy of the glands.  In clinical trials a modification of the Graefenberg ring was used.  This was termed the &quot;presear-ring&quot; and consisted of the addition of a flat ball in the center of the ring, thus increasing the surface area.  When compared with the Graefenberg ring the efficacy of the modified device was increased (5 pregnancies out of 53 vs. 1 pregnancy out of 73 cases, respectively).  Insertion of the device was easy and was performed on an outpatient basis.  Some gland proliferation was seen but without inflammation.  Pregnancy was possible after the ring was removed.  The materials used for the ring were gold or silver plated with gold.</AbstractText>
</OtherAbstract>
<KeywordList Owner="PIP">
<Keyword MajorTopicYN="N">Contraception</Keyword>
<Keyword MajorTopicYN="N">Contraceptive Methods</Keyword>
<Keyword MajorTopicYN="N">Family Planning</Keyword>
<Keyword MajorTopicYN="Y">Iud</Keyword>
<Keyword MajorTopicYN="N">Iud Material</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>15817151</PMID>
<DateCreated>
<Year>2005</Year>
<Month>04</Month>
<Day>08</Day>
</DateCreated>
<DateCompleted>
<Year>2005</Year>
<Month>06</Month>
<Day>16</Day>
</DateCompleted>
<DateRevised>
<Year>2007</Year>
<Month>11</Month>
<Day>14</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0014-4827</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>305</Volume>
<Issue>2</Issue>
<PubDate>
<Year>2005</Year>
<Month>May</Month>
<Day>1</Day>
</PubDate>
</JournalIssue>
<Title>Experimental cell research</Title>
<ISOAbbreviation>Exp. Cell Res.</ISOAbbreviation>
</Journal>
<ArticleTitle>The catenin p120ctn inhibits 
Kaiso-mediated transcriptional repression of the 
beta-catenin/TCF target gene 
matrilysin.</ArticleTitle>
<Pagination>
<MedlinePgn>253-65</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>The POZ-zinc finger transcription 
factor Kaiso was first identified as a specific 
binding partner for the Armadillo catenin and cell 
adhesion cofactor, p120ctn. Kaiso is a unique POZ 
protein with bi-modal DNA-binding properties; it 
associates with a sequence-specific DNA consensus 
Kaiso binding site (KBS) or methylated CpG 
dinucleotides, and regulates transcription of 
artificial promoters containing either site. 
Interestingly, the promoter of the 
Wnt/beta-catenin/TCF target gene matrilysin 
possesses two conserved copies of the KBS, which 
suggested that Kaiso might regulate matrilysin 
expression. In this study, we demonstrate using 
chromatin immunoprecipitation analysis that Kaiso 
associates with the matrilysin promoter in vivo. 
Minimal promoter assays further confirmed that 
Kaiso specifically repressed transcription of the 
matrilysin promoter; mutation of the KBS element or 
RNAi-mediated depletion of Kaiso abrogated this 
effect. More importantly, Kaiso blocked 
beta-catenin-mediated activation of the matrilysin 
promoter. Consistent with our previous findings, 
both Kaiso-DNA binding and Kaiso-mediated 
transcriptional repression of the matrilysin 
promoter were inhibited by overexpression of 
wild-type p120ctn, but not by a p120ctn mutant 
exhibiting impaired nuclear import. Collectively, 
our data establish Kaiso as a sequence-specific 
transcriptional repressor of the matrilysin 
promoter, and suggest that p120ctn and beta-catenin 
act in a synergistic manner, via distinct 
mechanisms, to activate matrilysin 
expression.</AbstractText>
</Abstract>
<Affiliation>Department of Biology, LSB-331, 
McMaster University, 1280 Main Street West, 
Hamilton, ON, Canada L8S 4K1.</Affiliation>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Spring</LastName>
<ForeName>Christopher M</ForeName>
<Initials>CM</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kelly</LastName>
<ForeName>Kevin F</ForeName>
<Initials>KF</Initials>
</Author>
<Author ValidYN="Y">
<LastName>O'Kelly</LastName>
<ForeName>Ita</ForeName>
<Initials>I</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Graham</LastName>
<ForeName>Monica</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Crawford</LastName>
<ForeName>Howard C</ForeName>
<Initials>HC</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Daniel</LastName>
<ForeName>Juliet M</ForeName>
<Initials>JM</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R01 CA-10012601</GrantID>
<Acronym>CA</Acronym>
<Agency>United States NCI</Agency>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
<PublicationType>Research Support, N.I.H., 
Extramural</PublicationType>
<PublicationType>Research Support, Non-U.S. 
Gov't</PublicationType>
<PublicationType>Research Support, U.S. Gov't, 
P.H.S.</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Exp Cell Res</MedlineTA>
<NlmUniqueID>0373226</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>CTNNB1 protein, 
human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Catnb protein, 
mouse</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Cell Adhesion 
Molecules</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Cytoskeletal 
Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Phosphoproteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Repressor 
Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Trans-Activators</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Transcription 
Factors</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>ZNF-kaiso protein, 
human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>beta Catenin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>cadherin-associated Src substrate 
p120</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.4.24.23</RegistryNumber>
<NameOfSubstance>Matrix Metalloproteinase 
7</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName 
MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Base 
Sequence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cell Adhesion 
Molecules</DescriptorName>
<QualifierName 
MajorTopicYN="N">genetics</QualifierName>
<QualifierName 
MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Chromatin 
Immunoprecipitation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cytoskeletal 
Proteins</DescriptorName>
<QualifierName 
MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName 
MajorTopicYN="N">Down-Regulation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Gene Expression 
Regulation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName 
MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Matrix 
Metalloproteinase 7</DescriptorName>
<QualifierName 
MajorTopicYN="Y">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName 
MajorTopicYN="N">Mice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Molecular Sequence 
Data</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName 
MajorTopicYN="N">Phosphoproteins</DescriptorName>
<QualifierName 
MajorTopicYN="N">genetics</QualifierName>
<QualifierName 
MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Promoter Regions 
(Genetics)</DescriptorName>
<QualifierName 
MajorTopicYN="N">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">RNA 
Interference</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Repressor 
Proteins</DescriptorName>
<QualifierName MajorTopicYN="Y">antagonists &amp; 
inhibitors</QualifierName>
<QualifierName 
MajorTopicYN="N">genetics</QualifierName>
<QualifierName 
MajorTopicYN="N">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName 
MajorTopicYN="N">Trans-Activators</DescriptorName>
<QualifierName 
MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Transcription 
Factors</DescriptorName>
<QualifierName MajorTopicYN="Y">antagonists &amp; 
inhibitors</QualifierName>
<QualifierName 
MajorTopicYN="N">genetics</QualifierName>
<QualifierName 
MajorTopicYN="N">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Transcription, 
Genetic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">beta 
Catenin</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
</MedlineCitationSet>
